By Catherine J. Frompovich
October 21, 2015
A huge hat tip goes to Sallie O Elkordy, who asked if anyone has contradicting information about E. coli being an ingredient in two meningococcal vaccines, for bringing this to my attention.
As readers can see from the below CDC Pinkbook of vaccine excipients and media, the two 2015 Meningococcal B vaccines Bexsero and Trumenba contain E. coli, so what can be expected from that ingredient being injected into the human bloodstream?
Bexsero [Novartis] contains 1.5 mg aluminum hydroxide (0.519 mg of Al3+) http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf pg. 8.
Kanomycin is an aminoglycoside antibiotic. So, what kind of adverse reactions can be expected from this mixture?
Trumenba [Pfizer] contains 0.018 mg of PS80 [polysorbate 80] and 0.25 mg of Al³+ as AlPO4 L [aluminum]
Furthermore, in the package insert Description (pg. 6), this is stated: The recombinant proteins are extracted from the production strains and purified through a series of column chromatography steps. Again, what adverse reactions can manifest from those ingredients?
Thimerosal is still in multi-dose vials of Menomune [Sanofi Pasteur] and formaldehyde is in Menveo [GlaxoSmithKline].
Readers are encouraged to do your research and homework regarding every vaccine’s ingredients/excipients. Here’s the link for all vaccine package inserts. Please study them carefully!
Catherine J Frompovich (website) is a retired natural nutritionist who earned advanced degrees in Nutrition and Holistic Health Sciences, Certification in Orthomolecular Theory and Practice plus Paralegal Studies. Her work has been published in national and airline magazines since the early 1980s. Catherine authored numerous books on health issues along with co-authoring papers and monographs with physicians, nurses, and holistic healthcare professionals. She has been a consumer healthcare researcher 35 years and counting.